Approval of unaudited financial results (Standalone and Consolidated) of the Company for the Half-year ended September 2025, and take note of the Limited Review Report of the Statutory Auditors.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Valencia Nutrition reported a strong turnaround in H1 FY26 (Apr-Sep 2025). Standalone revenue from operations more than doubled to ₹361.65 lakhs (vs ₹154.55 lakhs in H1 FY25), and the company swung from a loss of ₹121.81 lakhs to a profit of ₹59.30 lakhs (EPS of ₹0.35). On a consolidated basis, total revenue was ₹404.10 lakhs with a profit of ₹65.96 lakhs, aided by subsidiary Valencia Beverages & SuperWater contributing a small profit. However, operating cash flow was sharply negative at ₹(502.88) lakhs (consolidated), and cash balances dropped from ₹789.78 lakhs to ₹20.43 lakhs. Long-term borrowings surged from ₹148.67 lakhs to ₹1,779.14 lakhs, largely from related-party unsecured loans, used for setting up a manufacturing unit, new product launches, and the Valencia Online Platform.
Positive turnaround in profitability and revenue growth is encouraging for shareholders, but the steep rise in debt, near-empty cash balance, and large negative operating cash flow raise concerns about funding and liquidity. Short-term sentiment may improve on the profit comeback, but investors should watch how the manufacturing and online platform investments translate into sustained cash generation.